← All bills
HR 124In committeeHealthhouse
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Introduced Jan 3, 2025 by Rep. Al Green
IntroducedCommitteeFloorCongressLaw
It's waiting on a committee vote to reach the full chamber. Most bills never leave this stage.
Latest action · Jan 3, 2025
Referred to the House Committee on Energy and Commerce.
What it does
This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Summary by the Congressional Research Service.
Roll-call votes
No floor votes yet — it hasn't reached the floor of either chamber.